Affiliation:
1. Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences
2. Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences;
Research Centrum for Oncotheranostics, Tomsk Polytechnic University
Abstract
The article shows the feasibility of detecting and monitoring primary breast diffuse large B-cell lymphoma using single-photon emission computed tomography (SPECT) with 99mTc-1-thio-D-glucose (99mТс-TG), a new radiopharmaceutical. The innovative radiopharmaceutical makes it possible to evaluate the metabolism of tumor tissue without using positron emission tomography. The findings of 99mTc-TG SPECT obtained during diagnosis and monitoring of the patient were confirmed by the results of computed tomography. A comprehensive examination of the patient, including 99mTc-TG SPECT, made it possible to diagnose a rare case of primary breast lymphoma. Primary breast lymphoma accounts for 1.7–2.2 % of all extranodal nonHodgkin lymphomas. Diffuse large B-cell lymphoma is the most common histological type occurring usually as a unilateral palpable tumor in middle-aged women. Extranodal lymphomas account for less than 0.5 % of all malignant neoplasms of the breast. After 6 courses of immunochemotherapy, the patient underwent 99mTc-TG SPECT, which demonstrated persistent hypermetabolic activity in the breast. The patient received radiation therapy to the remaining tumor of the left breast. The patient is in remission and followed up at the Cancer Research Institute of Tomsk National Research Medical Center. Thus, 99mTc-TG SPECT is believed to be a promising method for visualizing primary breast lymphomas and assessing their treatment outcomes. It is an alternative to the standard approach using 18F-FDG positron emission tomography. The method compares favorably with positron emission tomography with its wide availability and low cost of study.
Publisher
Tomsk Cancer Research Institute
Reference18 articles.
1. Kaprin A.D., Starinskiy V.V., Petrova G.V. Malignant neoplasms in Russia in 2018 (morbidity and mortality). Moscow, 2018. 250 p. (in Russian).
2. Rukavicin O.A. Hematology: a national guide. Moscow, 2015. 912 p. (in Russian).
3. Kwee T.C., Kwee R.M., Nievelstein R.A. Imaging in staging of malignant lymphoma: a systematic review. Blood. 2008; 111: 504–16. doi: 10.1182/blood-2007-07-101899.
4. Chernov V.I., Dudnikova E.A., Gol’dberg V.E., Kravchuk T.L., Danilova A.V., Zel’chan R.V., Medvedeva A.A., Sinilkin I.G., Bragina O.D., Popova N.O., Gol’dberg A.V. Positron emission tomography in the diagnosis and monitoring of lymphoproliferative diseases. Мedical Radiology and Radiation Safety. 2018; 63(6): 41–50. (in Russian). doi: 10.12737/article_5c0b8d72a8bb98.40545646.
5. Pelosi E., Pregno P., Penna D., Deandreis D., Chiappella A., Limerutti G., Vitolo U., Mancini M., Bisi G., Gallo E. Role of whole-body [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) and conventional techniques in the staging of patients with Hodgkin and aggressive non Hodgkin lymphoma. Radiol Med. 2008; 113: 578–90. doi: 10.1007/s11547-008-0264-7.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献